Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TELA Bio (TELA) Research & Development (2018 - 2026)

TELA Bio has reported Research & Development over the past 8 years, most recently at $2.1 million for Q4 2025.

  • For Q4 2025, Research & Development rose 4.93% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $9.2 million, up 4.62%, while the annual FY2025 figure was $9.2 million, 4.62% up from the prior year.
  • Research & Development for Q4 2025 was $2.1 million at TELA Bio, down from $2.3 million in the prior quarter.
  • Over five years, Research & Development peaked at $2.7 million in Q4 2022 and troughed at $1.4 million in Q3 2021.
  • A 5-year average of $2.2 million and a median of $2.1 million in 2022 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: skyrocketed 97.14% in 2021 and later decreased 24.43% in 2024.
  • Year by year, Research & Development stood at $1.7 million in 2021, then soared by 58.03% to $2.7 million in 2022, then dropped by 1.5% to $2.7 million in 2023, then dropped by 24.43% to $2.0 million in 2024, then increased by 4.93% to $2.1 million in 2025.
  • Business Quant data shows Research & Development for TELA at $2.1 million in Q4 2025, $2.3 million in Q3 2025, and $2.2 million in Q2 2025.